Top compounds associated with response to EAPP


Feature Type Standardized
Nominal ANOVA
mRNA Bicalutamide GDSC1000 pan-cancer AAC 0.007 0.8
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0065 0.8
mRNA CBB-1007 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0071 0.8
mRNA dinaciclib CTRPv2 pan-cancer AAC -0.0099 0.8
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0069 0.8
mRNA Zebularine CTRPv2 pan-cancer AAC -0.0069 0.8
mRNA KU-60019 CTRPv2 pan-cancer AAC -0.007 0.8
mRNA Camptothecin GDSC1000 pan-cancer AAC 0.0068 0.8
mRNA lenalidomide FIMM pan-cancer AAC -0.034 0.8
Download CSV